Bluewater Clinical Research Group Incorporated

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease1 trial
• Obesity1 trial
• Stroke1 trial
• Type 2 diabetes1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Amgen2 trials

Running trials

• Active, not recruiting

  Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

  NCT06858878· Phase 3· Amgen· Source

Closed trials

• Completed

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· Phase 3· Amgen· Source